These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7148836)

  • 21. The plastic heparin lock.
    Scheidt WE
    Am J Surg; 1974 Jul; 128(1):118. PubMed ID: 4834905
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose of heparin.
    Handley AJ
    Br Med J; 1969 Mar; 1(5644):644. PubMed ID: 5766145
    [No Abstract]   [Full Text] [Related]  

  • 23. Continuous heparin anticoagulation in patients with arteriosclerosis and arterial emboli.
    Campbell HC; Hubbard SG; Ernst CB
    Surg Gynecol Obstet; 1980 Jan; 150(1):54-6. PubMed ID: 7350702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of heparin in healthy and obese subjects and in combination with dihydroergotamine.
    Beermann B; Lahnborg G
    Thromb Haemost; 1981 Feb; 45(1):24-6. PubMed ID: 7245123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of continuous infusion vs intermittent IV heparin.
    Self TH; Vanderbush RE
    Am Heart J; 1980 Jun; 99(6):816-8. PubMed ID: 7377107
    [No Abstract]   [Full Text] [Related]  

  • 27. Stability of diluted heparin sodium stored in plastic syringes.
    Tunbridge LJ; Lloyd JV; Penhall RK; Wise AL; Maloney T
    Am J Hosp Pharm; 1981 Jul; 38(7):1001-4. PubMed ID: 7258195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics of an unfractionated heparin (Liquemin) in the dog after intravenous and subcutaneous application based on heparin activity].
    Jacobs C; Grebe S; Kietzmann M; Mischke R
    Dtsch Tierarztl Wochenschr; 1999 Nov; 106(11):478-81. PubMed ID: 10609418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of thrombophlebitis of the extremities by paravasal and intraspongiosa infusions of a thrombolytic mixture].
    Askerkhanov RP; Zakariev ZM
    Vestn Khir Im I I Grek; 1982 Oct; 129(10):55-9. PubMed ID: 7179665
    [No Abstract]   [Full Text] [Related]  

  • 30. Tongue ischaemia in a patient with external carotid artery stenosis.
    Amen F; Amen AA
    J Laryngol Otol; 2002 Dec; 116(12):1053-4. PubMed ID: 12537623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of treatment of phlegmasia cerulea dolens of the lower limbs].
    Piskorz A; Napierała M
    Pol Przegl Chir; 1980 Mar; 52(3):211-5. PubMed ID: 7393768
    [No Abstract]   [Full Text] [Related]  

  • 33. [Focal caseous renal tuberculosis after the regional perfusion of antibacterial preparations].
    Shapkin AG
    Probl Tuberk; 1980 Apr; (4):65-9. PubMed ID: 7384033
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral heparins.
    Hiebert LM
    Clin Lab; 2002; 48(3-4):111-6. PubMed ID: 11934211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrocortisone, heparin, and peripheral intravenous infusion.
    Roongpisuthipong C; Puchaiwatananon O; Songchitsomboon S; Kanjanapanjapol S
    Nutrition; 1994; 10(3):211-3. PubMed ID: 7919671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted.
    Näsström B; Olivecrona G; Olivecrona T; Stegmayr BG
    J Lab Clin Med; 2001 Sep; 138(3):206-13. PubMed ID: 11528374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keeping indwelling intravenous devices patent: Hep-rinse.
    Drug Ther Bull; 1980 Jan; 18(1):4. PubMed ID: 7353479
    [No Abstract]   [Full Text] [Related]  

  • 39. Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin.
    Hamilton JF; Morrison PF; Chen MY; Harvey-White J; Pernaute RS; Phillips H; Oldfield E; Bankiewicz KS
    Exp Neurol; 2001 Mar; 168(1):155-61. PubMed ID: 11170730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin lock practice in total parenteral nutrition.
    Cottee S
    Prof Nurse; 1995 Oct; 11(1):25-6, 28-9. PubMed ID: 7568303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.